AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucotaj Met 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Taj Pharma India Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glucotaj Met 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glucotaj Met 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glucotaj Met 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glucotaj Met 2mg/500mg SR tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.

Common Side effects of Glucotaj Met 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucotaj Met 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glucotaj Met 2mg/500mg Tablet SR whole; do not fracture, pulverize, or chew it. Consume this extended-release tablet with a meal.

How Glucotaj Met 2mg/500mg Tablet SR works:

Glucotaj Met SR tablets (2mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glucotaj Met 2mg/500mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucotaj Met 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glucotaj Met 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Glucotaj Met 2mg/500mg SR tablets require careful administration. Dosage modifications may be necessary. A physician's consultation is recommended. In patients exhibiting severe kidney disease, Glucotaj Met 2mg/500mg SR tablets are contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucotaj Met 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In those with mild to moderate liver disease, Glucotaj Met 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in individuals with severe liver dysfunction.

What if you forget to take Glucotaj Met 2mg/500mg Tablet SR :

Should you forget to take a Glucotaj Met 2mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glucotaj Met 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucotaj Met 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glucotaj Met 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glucotaj Met and seek immediate medical attention.
Glucotaj Met 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glucotaj Met 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glucotaj Met 2mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glucotaj Met 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucotaj Met 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glucotaj Met 2mg/500mg Ta...
136
MRP 157
13% off